Annual Total Long Term Liabilities
$216.76 M
+$27.45 M+14.50%
December 31, 2023
Summary
- As of February 24, 2025, ABCL annual total long term liabilities is $216.76 million, with the most recent change of +$27.45 million (+14.50%) on December 31, 2023.
- During the last 3 years, ABCL annual total long term liabilities has risen by +$145.22 million (+203.00%).
- ABCL annual total long term liabilities is now at all-time high.
Performance
ABCL Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$235.17 M
+$4.03 M+1.74%
September 30, 2024
Summary
- As of February 24, 2025, ABCL quarterly total long term liabilities is $235.17 million, with the most recent change of +$4.03 million (+1.74%) on September 30, 2024.
- Over the past year, ABCL quarterly long term liabilities has stayed the same.
- ABCL quarterly long term liabilities is now at all-time high.
Performance
ABCL Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
ABCL Long Term Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +14.5% | 0.0% |
3 y3 years | +203.0% | 0.0% |
5 y5 years | +6183.7% | 0.0% |
ABCL Long Term Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +25.9% | at high | +47.2% |
5 y | 5-year | at high | +3958.5% | at high | +4303.0% |
alltime | all time | at high | +6183.7% | at high | +4303.0% |
AbCellera Biologics Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $235.17 M(+1.7%) |
Jun 2024 | - | $231.13 M(+1.2%) |
Mar 2024 | - | $228.30 M(+5.3%) |
Dec 2023 | $216.76 M(+14.5%) | $216.76 M(-1.1%) |
Sep 2023 | - | $219.18 M(-1.9%) |
Jun 2023 | - | $223.43 M(+11.8%) |
Mar 2023 | - | $199.83 M(+5.6%) |
Dec 2022 | $189.31 M | $189.31 M(-3.5%) |
Sep 2022 | - | $196.19 M(+22.8%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $159.79 M(-6.8%) |
Mar 2022 | - | $171.36 M(-0.5%) |
Dec 2021 | $172.16 M(+140.7%) | $172.16 M(+1.4%) |
Sep 2021 | - | $169.79 M(+48.4%) |
Jun 2021 | - | $114.42 M(+37.8%) |
Mar 2021 | - | $83.00 M(+16.0%) |
Dec 2020 | $71.54 M(+1239.4%) | $71.54 M(+116.5%) |
Sep 2020 | - | $33.04 M(+518.7%) |
Dec 2019 | $5.34 M(+54.8%) | $5.34 M |
Dec 2018 | $3.45 M | - |
FAQ
- What is AbCellera Biologics annual total long term liabilities?
- What is the all time high annual total long term liabilities for AbCellera Biologics?
- What is AbCellera Biologics annual total long term liabilities year-on-year change?
- What is AbCellera Biologics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for AbCellera Biologics?
- What is AbCellera Biologics quarterly long term liabilities year-on-year change?
What is AbCellera Biologics annual total long term liabilities?
The current annual total long term liabilities of ABCL is $216.76 M
What is the all time high annual total long term liabilities for AbCellera Biologics?
AbCellera Biologics all-time high annual total long term liabilities is $216.76 M
What is AbCellera Biologics annual total long term liabilities year-on-year change?
Over the past year, ABCL annual total long term liabilities has changed by +$27.45 M (+14.50%)
What is AbCellera Biologics quarterly total long term liabilities?
The current quarterly long term liabilities of ABCL is $235.17 M
What is the all time high quarterly long term liabilities for AbCellera Biologics?
AbCellera Biologics all-time high quarterly total long term liabilities is $235.17 M
What is AbCellera Biologics quarterly long term liabilities year-on-year change?
Over the past year, ABCL quarterly total long term liabilities has changed by $0.00 (0.00%)